Fund+

Investor type

PE / VC

Founded

2015

AUM

$200 M

Location

Belgium

Investment Ticket

$10-50 m

Investment Stage

Seed Series B Series A

Region of investment

Europe
Investor profile last updated: 04 November, 2021

Profile

Fund+ is an open-ended Fund for long term equity investment in innovative Life Sciences companies with a focus on Belgium. We want to create sustainable shareholders value, contribute to the development of a leadership position in the Life Sciences sector and generate a tangible, beneficial societal impact.

Industry

Healthcare Services Life Sciences HealthTech Biotechnology Medical Devices Pharmaceuticals MedTech

Contacts

Name
Title
Email
avatar
Louis Declerck Investment Analyst
Investment Analyst
-
avatar
Chris Buyse Managing Partner
Managing Partner
-
Upgrade to see contacts
avatar
47ynP5G1ImxJRSQ0 47ynP5G1ImxJRSQ0
47ynP5G1ImxJRSQ0
avatar
47ynP5G1ImxJRSQ0 47ynP5G1ImxJRSQ0
47ynP5G1ImxJRSQ0
avatar
47ynP5G1ImxJRSQ0 47ynP5G1ImxJRSQ0
47ynP5G1ImxJRSQ0
Investment-team contacts for Fund+ — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Fund+

Fund+ is a venture capital and private equity firm. It backs companies at Seed, Series B and Series A, writing tickets of $10-50 m.
Fund+ is located in Belgium.
Fund+ was founded in 2015.
Fund+ invests in companies and startups in Healthcare Services, Life Sciences, HealthTech, Biotechnology, Medical Devices, Pharmaceuticals, MedTech.
Fund+ invests in companies and startups in Europe.
Fund+ invests in companies and startups at Seed, Series B, Series A.
Fund+ usually invests $10-50 m on average.
Fund+ has around $200m assets under management.
Fund+ can be reached through its website fundplus.be and its LinkedIn page. Its general enquiries address is info@fundplus.be. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Fund+ — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Fund+ directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 04 November, 2021. Something out of date here? Report it — we re-run that firm within 48h and get back to you.